Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-26

Clinical Trial Update: Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports safety and effectiveness data for switching between two forms of tapentadol in adults with chronic low back pain, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2010-07-26